Home Supplements How We Rate Blog
Lagerstroemia speciosa

Banaba Leaf

Research reviewed: Up until 03/2026

Banaba Leaf (Lagerstroemia speciosa) is a dietary supplement with 9 published peer-reviewed studies involving 265 participants, researched for Blood Sugar Control, Insulin Sensitivity & Weight Management.

9
Studies
265
Participants
1999–2025
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Strong Evidence

Blood Sugar Control

Strong
4 studies 3 of 4 positive 102 participants 3 human

Insulin Sensitivity & Weight Management

Moderate
5 studies 3 of 5 positive 163 participants 2 human

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

5/9
Randomised
2/9
Double-Blind
1/9
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2011)
31
Study 2 (2022)
40
Study 3 (1999)
31
Study 4 (2012)
0
Study 5 (2008)
0
Study 6 (2009)
50
Study 7 (2006)
57
Study 8 (2025)
0

Research Timeline

When the studies were published

1
1999
1
2006
1
2008
1
2009
1
2011
1
2012
1
2014
1
2022
1
2025

All Studies

Detailed breakdown of each trial. Click to expand.

Blood Sugar Control

1

To assess Banaba extract on blood glucose in type 2 diabetics

2011 31 participants 2 weeks 32-48 mg/day corosolic acid
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised double-blind placebo-controlled

Purpose

To assess Banaba extract on blood glucose in type 2 diabetics

Dose

32-48 mg/day corosolic acid

Participants

31 type 2 diabetics

Duration

2 weeks

Results

Banaba extract significantly reduced fasting blood glucose levels. Corosolic acid identified as the active hypoglycemic compound. PMID: 22095937

How They Measured It

Fasting blood glucose, HbA1c, insulin

Read full study
2

To evaluate Banaba on metabolic syndrome, insulin sensitivity, and insulin secretion

2022 40 participants 3 months 1 g/day Banaba extract
Human Study RCT Positive

Study Type

Randomised controlled trial

Purpose

To evaluate Banaba on metabolic syndrome, insulin sensitivity, and insulin secretion

Dose

1 g/day Banaba extract

Participants

40 patients with metabolic syndrome

Duration

3 months

Results

Banaba significantly improved insulin sensitivity and reduced fasting glucose in metabolic syndrome. Effects consistent with prior clinical trials in T2DM. PMID: 34670472

How They Measured It

Fasting glucose, insulin, HOMA-IR, lipid profile

Read full study
3

To evaluate Banaba soft gel capsules on postprandial blood glucose

1999 31 participants Acute study + 2 weeks 10 mg corosolic acid/day
Human Study RCT Double-Blind Positive

Study Type

Randomised double-blind trial

Purpose

To evaluate Banaba soft gel capsules on postprandial blood glucose

Dose

10 mg corosolic acid/day

Participants

31 diabetics

Duration

Acute study + 2 weeks

Results

Pure corosolic acid significantly decreased blood sugar levels within 60 minutes. First human study confirming rapid hypoglycemic effect. PMID: 10482146

How They Measured It

Postprandial blood glucose at 30, 60, 90, 120 minutes

Read full study
4

To review Banaba and corosolic acid for diabetes management and complications

2012 ? participants N/A Various
Review/Other Mixed

Study Type

Review

Purpose

To review Banaba and corosolic acid for diabetes management and complications

Dose

Various

Participants

N/A

Duration

N/A

Results

Banaba and its constituents (corosolic acid, ellagitannins) have demonstrated hypoglycemic effects via glucose transport stimulation, alpha-glucosidase inhibition, and PPAR-gamma activation. PMCID: PMC3468018

How They Measured It

Systematic literature review

Read full study

Insulin Sensitivity & Weight Management

5

To investigate corosolic acid mechanism on disaccharide hydrolysis and glucose absorption

2008 ? participants N/A Various concentrations
In Vitro Mixed

Study Type

In vitro study

Purpose

To investigate corosolic acid mechanism on disaccharide hydrolysis and glucose absorption

Dose

Various concentrations

Participants

Cell cultures and enzyme assays

Duration

N/A

Results

Corosolic acid inhibited alpha-glucosidase activity and increased cellular glucose uptake via GLUT4 translocation, explaining blood glucose lowering effect. PMID: 18635916

How They Measured It

Alpha-glucosidase inhibition, glucose uptake assays

Read full study
6

To assess Banaba extract on weight management in overweight subjects

2009 50 participants 12 weeks 10 mg corosolic acid/day
Human Study RCT Positive

Study Type

Randomised controlled trial

Purpose

To assess Banaba extract on weight management in overweight subjects

Dose

10 mg corosolic acid/day

Participants

50 overweight adults

Duration

12 weeks

Results

Banaba supplementation significantly reduced body weight (2.5 kg), BMI, and improved glucose tolerance vs placebo in overweight subjects.

How They Measured It

Body weight, BMI, waist circumference, glucose tolerance

Read full study
7

To investigate Banaba on obesity and insulin resistance in high-fat diet mice

2006 57 participants 8 weeks 200 mg/kg corosolic acid
Animal Study Positive

Study Type

Animal study

Purpose

To investigate Banaba on obesity and insulin resistance in high-fat diet mice

Dose

200 mg/kg corosolic acid

Participants

C57BL/6 mice

Duration

8 weeks

Results

Banaba extract significantly reduced body weight, improved insulin sensitivity, and normalized adipokine levels in obese mice. PPAR-gamma pathway identified. PMID: 16949897

How They Measured It

Body weight, insulin sensitivity, adipokines

Read full study
8

To explore nutraceutical solutions including Banaba for prediabetes management

2025 ? participants N/A Various
Review/Other Mixed

Study Type

Review

Purpose

To explore nutraceutical solutions including Banaba for prediabetes management

Dose

Various

Participants

N/A

Duration

N/A

Results

Banaba (Lagerstroemia speciosa) leaf extract rich in corosolic acid reduces fasting plasma glucose, HbA1c, and insulin levels in clinical studies, particularly in T2D patients. PMID: 40613623

How They Measured It

Literature review of clinical evidence

Read full study
9

To assess Banaba on lipid profile and inflammation in metabolic syndrome

2014 56 participants 8 weeks 500 mg/day extract
Human Study RCT Positive

Study Type

Randomised controlled trial

Purpose

To assess Banaba on lipid profile and inflammation in metabolic syndrome

Dose

500 mg/day extract

Participants

56 metabolic syndrome patients

Duration

8 weeks

Results

Banaba supplementation significantly improved lipid profile and reduced hs-CRP vs placebo in metabolic syndrome patients. Consistent with glucose-lowering effects.

How They Measured It

Total cholesterol, LDL, HDL, triglycerides, hs-CRP

Read full study

Frequently Asked Questions

Common questions about Banaba Leaf research

What does the research say about Banaba Leaf?

There are currently 9 peer-reviewed studies on Banaba Leaf (Lagerstroemia speciosa), involving 265 total participants. Research covers Blood sugar control, Insulin sensitivity, Weight management. The overall evidence strength is rated as Strong.

How strong is the evidence for Banaba Leaf?

The evidence is currently rated as "Strong Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (5 human studies, 1 animal study), and reported outcomes.

What health goals has Banaba Leaf been studied for?

Banaba Leaf has been researched for: Blood sugar control, Insulin sensitivity, Weight management. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Banaba Leaf based on human trials?

Yes, 5 out of 9 studies are human trials. The remaining 1 is an animal study. Human trials carry more weight in our evidence scoring system.